Live feed
Filing
SC 13D/A
SC 13D/A0000947871-17-000761·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
Roka BioScience, Inc.
Security class unavailable · CUSIP: 775431109
Event date: 2017-09-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,247,721
- Percent of class
- 22.3600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-17-000761
- Form type
- SC 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Sep 28, 2017
- Reporting period
- Sep 26, 2017
- Description
- Schedule 13D beneficial ownership